We are currently providing early access to a select group of researchers. Please email the team to request access, or wait for the official public announcement.
A $3B+ market. Built for researchers the world forgot.
India produces the 3rd largest number of bioscience researchers globally.
Yet every single one of them is underserved — by price, by language, by relevance.
7 Lakh+
Bioscience researchers in India
₹ 1,00,000+
What SciFinder costs per year
₹TBA/mo
TRACTION
From concept to deployment. Built to scale.
✓
FastAPI Backend Live
Smart routing architecture operational across Groq and Gemini APIs.
Claude Sonnet integration ready and staged for deployment.
✓
Orin AI Brain Deployed
Domain-specific reasoning architecture live. 4-layer scientific
framework — Mechanism, Evidence, Clinical Relevance, and Limitations —
embedded and active.
✓
Multi-Model Architecture
~80% of queries handled free via Groq LLaMA3 and Gemini Flash. Claude
reserved for complex scientific reasoning — cost-efficient by design.
✓
Scientific Database Architecture Ready
PubMed, PubChem, ChEMBL, KEGG, and Semantic Scholar — fully
mapped and integrated into Orin's research pipeline.
✓
Indian Language Support
Sarvam AI STT/TTS scoped and staged for integration. Hindi, Telugu,
Tamil, Kannada, and Bengali voice support in active development.
✓
Landing Page & Investor Portal Live
Professional web presence live with product overview, pricing, and
direct investor contact form operational.
FOUNDING TEAM
Meet our people.
A team at the intersection of biology, technology, and a shared belief that
research tools should be accessible to every scientist in India.
RK
Rahul Kota
Founder & CEO
RK
Rihan Kota
Co-Founder & Board Advisor
AD
Arkoparno Das
Co-Founder & Chief Scientific Officer
RC
Rushi Chaganti
Co-Founder & Chief Technology Officer
AA
Ajay Andhukuri
Co-Founder & Social Media, Marketing Head
WHY NOW
The timing has never been better.
01
AI Has Reached Research Grade
Models like Claude Sonnet now reason at PhD level across complex scientific
domains.
02
India's Pharma & Biotech Sector is Exploding
India is the 3rd largest pharma producer globally with 3,000+ FDA-approved
plants.
03
Free APIs Changed Everything
PubMed, PubChem, ChEMBL — world-class databases now free to access
programmatically.
04
No Credible Indian Competitor
Zero domain-specific bioscience AI exists for the Indian market. The gap is
wide open.
THE ASK
Join us at the ground floor.
We are raising our first round to accelerate product development,
expand our team, and acquire our first 1,000 paying users.